-
公开(公告)号:AU1929588A
公开(公告)日:1989-01-27
申请号:AU1929588
申请日:1988-07-22
Applicant: HOECHST AG
Inventor: WESS GUNTHER , BARTMANN WILHELM , BECK GERHARD , ANAGNOSTOPOULOS HIRISTOS
IPC: A61K31/38 , A61K31/085 , A61K31/10 , A61K31/12 , A61K31/165 , A61K31/19 , A61K31/215 , A61K31/22 , A61K31/34 , A61K31/381 , A61K31/395 , A61K31/41 , A61K31/44 , A61K31/535 , A61K31/5375 , A61P1/04 , A61P11/00 , A61P17/00 , A61P29/00 , A61P37/08 , A61P43/00 , C07C41/00 , C07C43/00 , C07C43/178 , C07C43/20 , C07C43/235 , C07C43/263 , C07C45/00 , C07C47/52 , C07C49/84 , C07C51/00 , C07C59/125 , C07C65/21 , C07C67/00 , C07C69/007 , C07C69/025 , C07C69/675 , C07C69/92 , C07C201/00 , C07C235/06 , C07C235/16 , C07C239/00 , C07C239/14 , C07C313/00 , C07C317/00 , C07C317/04 , C07C317/18 , C07C317/22 , C07C317/24 , C07C317/44 , C07C317/46 , C07C323/00 , C07C323/16 , C07C323/19 , C07C323/22 , C07C323/52 , C07C323/56 , C07C323/60 , C07C323/65 , C07D213/30 , C07D257/04 , C07D295/18 , C07D317/36 , C07D317/38 , C07D333/16 , C07C149/273 , C07C147/14 , C07C147/06 , A61K31/185 , A61K31/255 , C07D317/22
Abstract: Leukotriene antagonists, a process for the preparation thereof, and the use thereof for the treatment of diseases (I) in which R1, R2, R3, R4, R5 and X have the indicated meanings, a process for the preparation of these compounds, the use thereof as pharmaceuticals, and pharmaceutical products based on these compounds, are described.
-
公开(公告)号:ES2001595A6
公开(公告)日:1988-06-01
申请号:ES8601385
申请日:1986-08-27
Applicant: HOECHST AG
Inventor: BECK GERHARD , VON KEREKJARTO BELA , LAU HANS-HERMANN , WESS GUNTHER
IPC: A61K31/35 , A61K31/351 , A61K31/365 , A61K31/366 , A61K31/38 , C07D409/06 , A61K31/381 , A61P3/06 , A61P9/10 , C07C51/00 , C07C51/09 , C07C57/30 , C07C57/58 , C07C59/48 , C07C59/54 , C07C59/56 , C07C59/64 , C07C59/72 , C07C67/00 , C07C67/08 , C07C69/66 , C07C69/732 , C07C69/734 , C07D309/10 , C07D309/30 , C07D333/00 , C07D333/16 , C07D333/24 , C07D409/10 , C07F7/18 , C07F9/54
Abstract: EL PROCEDIMIENTO DESCRITO PREPARA COMPUESTOS DE FORMULA DONDE A-B SIGNIFICA -CFFCH- O -CH2-CH2-, Z SIGNIFICA -CH2- O -CH2-CH2, R1 SIGNIFICA UN RADICAL ORGANICO, R2 Y R3 SIGNIFICAN HIDROGENO, HALOGENO O UN RADICAL ORGANICO, Y R4 SIGNIFICA HIDROGENO, METAL ALCALINO, AMONIO O UN RADICAL ORGANICO, HACIENDO REACCIONAR LAS SALES DE FOSFONIO DE FORMULA II CON EL ALDEHIDO QUIRAL DE FORMULA III
-
公开(公告)号:AU6202986A
公开(公告)日:1987-03-05
申请号:AU6202986
申请日:1986-08-28
Applicant: HOECHST AG
Inventor: WESS GUNTHER , GRANZER ERNOLD , BECK GERHARD , LAU HANS-HERMANN
IPC: A61K31/365 , C07D309/10 , C07D309/30 , C07F7/18 , C07D409/12 , C07D409/14 , C07D405/12 , C07D405/14 , A61K31/35 , A61K31/38 , A61K31/44
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one of the general formula I see diagramm : EP0216127,P57,F1 in which R**1 and R**5 are identical or different and denote a) halogen, b) cycloalkyl having 4-8 carbon atoms, or a phenyl radical which can be substituted in the nucleus once to 3 times by halogen, trifluoromethyl, and/or alkyl or alkoxy each having 1-4 carbon atoms, or c) a straight-chain or branched alkyl radical having 1 to 18 carbon atoms, or a straight-chain or branched alkenyl radical having 2 to 18 carbon atoms, it being possible for the alkyl and alkenyl radicals in turn to be substituted 1-3 times by alpha) straight-chain or branched alkoxy radicals having up to 10 carbon atoms, or cycloalkyl radicals having 3 to 7 carbon atoms, or straight-chain or branched alkenyloxy or alkynyloxy radicals having 3 to 6 carbon atoms, beta) halogen, hydroxyl, cycloalkyl having 3-7 carbon atoms, unsubstituted phenyl or alpha- or beta-thienyl radicals, or phenyl or alpha- or beta-thienyl radicals which in turn are substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy having 1-4 carbon atoms, gamma) unsubstituted phenoxy, benzyloxy, alpha- or beta-thienyloxy radicals, or phenoxy, benzyloxy, alpha- or beta-thienyloxy radicals which in turn are substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy having 1 to 4 carbon atoms, delta) the group see diagramm : EP0216127,P57,F2 R**6 denoting : a straight-chain or branched alkyl or alkenyl radical having up to 8 carbon atoms, or a cycloalkyl or cycloalkenyl radical each having 3-8 carbon atoms, or an unsubstituted phenyl radical, or a phenyl radical which in turn is substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy having 1-4 carbon atoms, or a 3-pyridyl radical, R**2 and R**4 denote hydrogen, and R**3 is alkyl or alkenyl having up to 4 carbon atoms, halogen or alkoxy having 1-4 carbon atoms, and the corresponding open-chain dihydroxy carboxylic acid, their pharmacologically tolerated salts with bases, and their pharmacologically tolerated esters. 1. Claims for the Contracting State : AT A process for the preparation of a 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one of the general formula I see diagramm : EP0216127,P62,F1 in which R**1 and R**5 are identical or different and denote a) halogen, b) cycloalkyl having 4-8 carbon atoms, or a phenyl radical which can be substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy each having 1-4 carbon atoms, or c) a straight-chain or branched alkyl radical having 1 to 18 carbon atoms, or a straight-chain or branched alkenyl radical having 2 to 18 carbon atoms, it being possible for the alkyl and alkenyl radicals in turn to be substituted 2-3 times by alpha) straight-chain or branched alkoxy radicals having up to 10 carbon atoms, or cycloalkoxy radicals having 3 to 7 carbon atoms, or straight-chain or branched alkenyloxy or alkynyloxy radicals having 3 to 6 carbon atoms, beta) halogen, hydroxyl, cycloalkyl having 3-7 carbon atoms, unsubstituted phenyl or alpha- or beta-thienyl radicals, or phenyl or alpha- or beta-thienyl radicals which in turn are substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy having 1-4 carbon atoms, gamma) unsubstituted phenoxy, benzyloxy, alpha- or beta-thienyloxy radicals, or phenoxy, benzyloxy, alpha- or beta-thienyloxy radicals which in turn are substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy having 1 to 4 carbon atoms, delta) the group see diagramm : EP0216127,P62,F2 R**6 denoting : a straight-chain or branched alkyl or alkenyl having up to 8 carbon atoms, or a cycloalkyl or cycloalkenyl radical each having 3-8 carbon atoms, or an unsubstituted phenyl radical, or a phenyl radical which in turn is substituted in the nucleus once to 3 times by halogen, trifluoromethyl and/or alkyl or alkoxy having 1-4 carbon atoms, or a 3-pyridyl radical, R**2 and R**4 denote hydrogen, and R**3 is alkyl or alkenyl having up to 4 carbon atoms, halogen or alkoxy having 1-4 carbon atoms, and the corresponding open-chain dihydroxy carboxylic acid, their pharmacologically tolerated salts with bases, and their pharmacologically tolerated esters, which comprises a) conversion of an appropriately substituted phenol of the formula II see diagramm : EP0216127,P62,F3 in which R**1 , R**2 , R**3 , R**4 and R**5 have the indicated meanings, with the chiral iodide of the formula III see diagramm : EP0216127,P63,F1 in which R**10 denotes a protective group which is stable to bases and weak acids, into an ether of the formula IV see diagramm : EP0216127,P63,F2 in which R**1 to R**5 have the meanings indicated for formula I and R**10 has the meanings indicated for formula III, b) hydrolysis of the ether of the formula IV to give the corresponding hemiacetal of the formula V see diagramm : EP0216127,P63,F3 in which R**1 to R**5 and R**10 have the meanings indicated for formula I or III, c) oxidation of the hemiacetal of the formula V to give the corresponding lactone of the formula VI see diagramm : EP0216127,P64,F1 in which R**1 to R**5 have the meanings indicated for formula I and R**10 has the meanings indicated for formula III, and d) conversion of the protected hydroxylactone of the formula VI into the 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one of the formula I see diagramm : EP0216127,P64,F2 where appropriate the compound of the formula I which has been obtained being converted into the corresponding open-chain dihydroxy carboxylic acid of the formula VII see diagramm : EP0216127,P64,F3 its salt or its ester, where appropriate a salt or ester which has been obtained being converted into the free dihydroxy carboxylic acid or, where appropriate, the free carboxylic acid being converted into the salt or ester.
-
公开(公告)号:CA2123052C
公开(公告)日:2005-04-26
申请号:CA2123052
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: GLOMBIK HEINER , ENHSEN ALFONS , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61K31/58 , A61P3/06 , A61P9/10 , C07J9/00 , C07J31/00 , C07J41/00 , C07J43/00 , C07J51/00 , C07J17/00 , A61K31/56
Abstract: Monomeric bile acid derivatives of the formula I Z-X-GS I, in which GS, X and Z have the meanings given, and processes for their preparation are described. The compounds have useful pharmacological properties and can therefore be used as medicaments.
-
公开(公告)号:NO304795B1
公开(公告)日:1999-02-15
申请号:NO941677
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61K31/58 , A61K31/675 , A61P3/06 , A61P9/10 , C07J9/00 , C07J17/00 , C07J41/00 , C07J43/00
Abstract: Tetrazole bile acid derivatives of the formula I G1 - X - G2 I in which G1, G2 and X have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
-
公开(公告)号:NO304794B1
公开(公告)日:1999-02-15
申请号:NO941680
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: GLOMBIK HEINER , ENHSEN ALFONS , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61K31/58 , A61P3/06 , A61P9/10 , C07J9/00 , C07J31/00 , C07J41/00 , C07J43/00 , C07J51/00
Abstract: Monomeric bile acid derivatives of the formula I Z-X-GS I, in which GS, X and Z have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
-
37.
公开(公告)号:NZ247827A
公开(公告)日:1995-08-28
申请号:NZ24782793
申请日:1993-06-09
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
Abstract: Bile acid derivatives of the formula I Z(X-GS)n in which GS, X, Z and n have the stated meanings, and a process for the production of these compounds are described. The compounds have pharmacological activity and can therefore be used as pharmaceuticals, in particular as hypolipidaemic.
-
公开(公告)号:PT88073B
公开(公告)日:1995-03-01
申请号:PT8807388
申请日:1988-07-22
Applicant: HOECHST AG
Inventor: BECK GERHARD , ANAGNOSTOPULOS HIRISTO , BARTMANN WILHELM , WESS GUNTHER
IPC: A61K31/085 , A61K31/10 , A61K31/12 , A61K31/165 , A61K31/19 , A61K31/215 , A61K31/38 , A61K31/22 , A61K31/34 , A61K31/381 , A61K31/395 , A61K31/41 , A61K31/44 , A61K31/535 , A61K31/5375 , A61P1/04 , A61P11/00 , A61P17/00 , A61P29/00 , A61P37/08 , A61P43/00 , C07C41/00 , C07C43/00 , C07C43/178 , C07C43/20 , C07C43/235 , C07C43/263 , C07C45/00 , C07C47/52 , C07C49/84 , C07C51/00 , C07C59/125 , C07C65/21 , C07C67/00 , C07C69/007 , C07C69/025 , C07C69/675 , C07C69/92 , C07C201/00 , C07C235/06 , C07C235/16 , C07C239/00 , C07C239/14 , C07C313/00 , C07C317/00 , C07C317/04 , C07C317/18 , C07C317/22 , C07C317/24 , C07C317/44 , C07C317/46 , C07C323/00 , C07C323/16 , C07C323/19 , C07C323/22 , C07C323/52 , C07C323/56 , C07C323/60 , C07C323/65 , C07D213/30 , C07D257/04 , C07D295/18 , C07D317/36 , C07D317/38 , C07D333/16
Abstract: Leukotriene antagonists, a process for the preparation thereof, and the use thereof for the treatment of diseases (I) in which R1, R2, R3, R4, R5 and X have the indicated meanings, a process for the preparation of these compounds, the use thereof as pharmaceuticals, and pharmaceutical products based on these compounds, are described.
-
公开(公告)号:NZ260468A
公开(公告)日:1995-02-24
申请号:NZ26046894
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
IPC: A61P3/06 , A61P9/00 , C07J3/00 , A61K31/575 , C07J7/00 , C07J9/00 , C07J31/00 , C07J41/00 , C07J51/00
Abstract: nor-Bile acid derivatives of the formula I G1 - X - G2 I, in which G1, G2 and X have the stated meanings, processes for preparing these compounds and medicines are described. On the basis of their pharmacological action, they can be used as antihyperlipidaemic.
-
公开(公告)号:PT90532B
公开(公告)日:1994-11-30
申请号:PT9053289
申请日:1989-05-11
Applicant: HOECHST AG
Inventor: JENDRALLA HEINER , BARTMANN WILHELM , WESS GUNTHER , BEACK GERHARD
IPC: A61K31/365 , A61K31/185 , A61K31/19 , A61K31/35 , A61K31/366 , A61P3/06 , C07C39/367 , C07C59/64 , C07C59/68 , C07C323/01 , C07C323/09 , C07D309/30
Abstract: Compounds of the general formula I and the corresponding open-chain dihydroxy carboxylic acids of the formula II in which X, Y and Z have the stated meanings, and their pharmacologically tolerated salts with bases and their pharmacologically tolerated esters, process for preparing this compound, its use as pharmaceutical and pharmaceutical products are described. Also described are phenols and thiophenols of the formula III in which X, Y and Z have the stated meanings.
-
-
-
-
-
-
-
-
-